Walleye Capital
WST icon

Walleye Capital’s West Pharmaceutical WST Stock Holding History

Walleye Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$27.5K – 5065
2025
Q4 		$27.5K Buy
+100
New +$27.4K ﹤0.01% 4200
2025
Q3 		– Sell
-2,500
Closed -$547K – 5219
2025
Q2 		$547K Buy
2,500
+1,200
+92% +$257K ﹤0.01% 2573
2025
Q1 		$291K Buy
1,300
+1,200
+1,200% +$331K ﹤0.01% 2979
2024
Q4 		$32.8K Sell
100
-3,800
-97% -$1.2M ﹤0.01% 4434
2024
Q3 		$1.17M Sell
3,900
-700
-15% -$214K ﹤0.01% 2487
2024
Q2 		$1.52M Buy
+4,600
New +$1.63M ﹤0.01% 2395
2024
Q1 		– Sell
-200
Closed -$70.4K – 5957
2023
Q4 		$70.4K Sell
200
-100
-33% -$35.4K ﹤0.01% 4195
2023
Q3 		$113K Buy
+300
New +$116K ﹤0.01% 3889

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's WST Position: Q1 2026 in Review

Walleye Capital sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 134,453 shares — an estimated $37M sold.

Walleye Capital first reported a position in WST in Q2 2022 and held it in 12 quarters. The position peaked at $37M in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Walleye Capital reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 134,453 West Pharmaceutical shares in Q1 2026, an estimated $37M.
  • Walleye Capital first reported a position in West Pharmaceutical in Q2 2022 and held it in 12 quarters.
  • Walleye Capital's West Pharmaceutical position peaked at $37M in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.